Journal of Pediatrics and Mother Care

Editor in Chief

Dr. Charleta Guillory, M.D., M.P.H, F.A.A.P., is an Associate Professor of Pediatrics in the Section of Neonatology at Baylor College of Medicine, Director of Level II Nurseries at Texas Children’s Hospital and Director of Texas Children's Hospital Neonatal-Perinatal Public Health Program. She earned her doctor of medicine degree from the Louisiana State University Medical School, completed…

Name : Charleta Guillory
University : Baylor College of Medicine

Indexing and Listing

          

Recent Articles

  • article image

    Food Cravings and Aversions during Pregnancy: A Current Snapshot

    Food cravings are very common during pregnancy, along with food aversions in many instances, yet their underlying causes are not well understood. Food cravings are usually met with the consumption of the craved food, which generally include unhealthy foods, that is, sweet/fat and salty/spicy foods. It is important to follow a healthy diet during pregnancy…

    View more
  • article image

    The Development of the Mother-Infant Mutualistic Screening Scale

    Background: The integrity of a mother-infant dyad is essential for the proper development of maternal behavior and infant growth/ development. At present, there is a lack of objective approaches to monitor mother-infant behavioral exchanges.

    View more
  • article image

    Think Thymus, Think Well: the Chest X-Ray Thymic Signs

    Chest x-ray is one of the most requested imaging tools for infants. Actually, in spite of continuing trends of radiology in diminishing the importance of conventional thorax radiology, neonatal radiography is still essential for clinicians. Therefore, it is important to have wide knowledge of typical signs of this examination. This article is focused…

    View more

PubMed Indexed Articles

  • article image

    Homeodomain Transcription Factor Msx-2 Regulates Uterine Progenitor Cell Response to Diethylstilbestrol

    The fate of mouse uterine epithelial progenitor cells is determined between postnatal days 5 to 7. Around this critical time window, exposure to an endocrine disruptor, diethylstilbestrol (DES), can profoundly alter uterine cytodifferentiation. We have shown previously that a homeo domain transcription factor MSX-2 plays an important role in DES-responsiveness…

    View more
  • article image

    Brain Uptake of Neurotherapeutics after Intranasal Delivery in Mice

    There is a growing global prevalence of neurodegenerative diseases such as Alzheimer’s disease and dementia. Current treatment for neurodegenerative diseases is limited due to the blood brain barrier’s ability to restrict the entry of therapeutics to the brain. In that context, direct delivery of drugs from nose to brain has gained emerging interest…

    View more
  • article image

    Current Studies of Immunotherapy on Glioblastoma

    Glioblastoma is a form of brain tumor with a very high morbidity and mortality. Despite decades of research, the best treatments currently in clinical practice only extend survival by a number of months. A promising alternative to conventional treatment for glioblastomas is immunotherapy. Although proposed over a century ago, the field of cancer immunotherapy…

    View more

Testimonial